{{Rsnum
|rsid=1327301
|Chromosome=X
|position=51467205
|Orientation=plus
|GMAF=0.2098
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 53.1 | 18.6 | 28.3
| HCB | 91.2 | 8.0 | 0.7
| JPT | 85.0 | 10.6 | 4.4
| YRI | 81.0 | 10.9 | 8.2
| ASW | 70.2 | 24.6 | 5.3
| CHB | 91.2 | 8.0 | 0.7
| CHD | 87.0 | 7.4 | 5.6
| GIH | 45.5 | 20.8 | 33.7
| LWK | 75.5 | 17.3 | 7.3
| MEX | 75.9 | 17.2 | 6.9
| MKK | 79.5 | 12.2 | 8.3
| TSI | 57.4 | 19.8 | 22.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19767753
|Trait=Prostate cancer
|Title=Identification of seven new prostate cancer susceptibility loci through a genome-wide association study
|RiskAllele=T
|Pval=2E-10
|OR=NR
|ORtxt=NR
|OA=1
}}

{{PMID Auto
|PMID=19549809
|Title=Fine-mapping and family-based association analyses of prostate cancer risk variants at Xp11.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1327301
|overall_frequency_n=28
|overall_frequency_d=92
|overall_frequency=0.304348
|n_genomes=15
|n_genomes_annotated=0
|n_haplomes=26
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}